Multi-Organ Denervation With the iRF System to RedUce Sympathetic Drive

NAUnknownINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 13, 2021

Primary Completion Date

October 1, 2022

Study Completion Date

October 1, 2023

Conditions
HypertensionType 2 DiabetesMetabolic Syndrome
Interventions
DEVICE

iRF System Multi-organ Denervation

If assigned to the treatment arm, subjects will remain blinded and recieve angiography prior to catheter based RF ablation to circumferentially disrupt the sympathetic nerves surrounding the target arteries

OTHER

Control Procedure

If assigned to the control group, subjects will remain blinded and recieve angiography of the target arteries prior to sheath removal.

Trial Locations (2)

0112

RECRUITING

Israeli-Georgian Medical Research Clinic Helsicore, Tbilisi

0159

RECRUITING

Tbilisi Heart and Vascular Clinic, Tbilisi

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Metavention

INDUSTRY

NCT04917393 - Multi-Organ Denervation With the iRF System to RedUce Sympathetic Drive | Biotech Hunter | Biotech Hunter